Below are the earnings highlights for Edwards Lifesciences Corp. (EW):
-Net Income: $124.4 Mln in Q2 vs. $94.0 Mln in the same period last year.
-EPS: $1.13 in Q2 vs. $0.88 in the same period last year.
-Analysts projected $1.05 per share
-Revenue: $616.8 Mln in Q2 vs. $575.1 Mln in the same period last year.
-Guidance:
Full year EPS guidance: $4.30 - $4.40
Full year revenue guidance: $2.3 Bln - $2.5 Bln
For comments and feedback contact: editorial@rttnews.com